RP-001
N/A
Report date: 2026/05/20 20:02:01
Base Information
Drug NameRP-001
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRetiPharma
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A